gliclazide has been researched along with Brain Ischemia in 1 studies
Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.
Brain Ischemia: Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gliclazide was administered intravenously into the right jugular vein for 12h simultaneously with the reperfusion." | 1.40 | Protective effect of treatment with low-dose gliclazide in a model of middle cerebral artery occlusion and reperfusion in rats. ( Li, H; Ma, M; Tan, F; Yu, Y, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tan, F | 1 |
| Li, H | 1 |
| Ma, M | 1 |
| Yu, Y | 1 |
1 other study available for gliclazide and Brain Ischemia
| Article | Year |
|---|---|
Protective effect of treatment with low-dose gliclazide in a model of middle cerebral artery occlusion and reperfusion in rats.
Topics: Animals; Apoptosis; Blood Glucose; Brain; Brain Ischemia; Disease Models, Animal; Gene Expression; G | 2014 |